X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (714) 714
Publication (89) 89
Book Chapter (10) 10
Book Review (5) 5
Conference Proceeding (3) 3
Newspaper Article (3) 3
Dissertation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (412) 412
humans (404) 404
blys protein (326) 326
blys (322) 322
immunology (282) 282
lymphocytes b (271) 271
animals (244) 244
baff (244) 244
mice (204) 204
female (199) 199
male (175) 175
necrosis-factor family (164) 164
b-lymphocytes - immunology (160) 160
b cells (154) 154
systemic lupus erythematosus (143) 143
middle aged (131) 131
adult (129) 129
april (129) 129
lymphocytes (128) 128
autoimmune-disease (124) 124
lupus (123) 123
cell survival (118) 118
survival (116) 116
cytokines (115) 115
b-lymphocyte stimulator (114) 114
autoimmune diseases (110) 110
rheumatology (109) 109
systemic-lupus-erythematosus (107) 107
autoimmunity (102) 102
expression (100) 100
b-cell activating factor - metabolism (95) 95
lymphocytes t (95) 95
immunoglobulins (92) 92
proteins (91) 91
autoantibodies (90) 90
medicine (90) 90
ligands (89) 89
immune system (88) 88
enzyme-linked immunosorbent assay (87) 87
flow cytometry (87) 87
research article (86) 86
inflammation (85) 85
apoptosis (84) 84
taci (84) 84
multidisciplinary sciences (82) 82
b-lymphocytes - metabolism (81) 81
b-cell activating factor (80) 80
b-cell activating factor - genetics (80) 80
patients (80) 80
rheumatoid arthritis (80) 80
science (80) 80
april protein (79) 79
lymphocyte stimulator (79) 79
b-cell activating factor - blood (77) 77
aged (75) 75
gene expression (74) 74
tumor necrosis factor (74) 74
disease (73) 73
receptor (72) 72
signal transduction (71) 71
arthritis (70) 70
b-cell activating factor - immunology (70) 70
cell proliferation (69) 69
lupus erythematosus, systemic - immunology (69) 69
antibodies (68) 68
cell activation (68) 68
cell biology (68) 68
rheumatoid-arthritis (68) 68
pathogenesis (67) 67
immune system diseases (66) 66
rituximab (65) 65
antigens (64) 64
immunoglobulin g (61) 61
receptors (61) 61
research (61) 61
activation (59) 59
analysis (59) 59
baff-r (59) 59
homeostasis (58) 58
immune response (58) 58
biochemistry & molecular biology (56) 56
tnf family (56) 56
article (55) 55
dendritic cells (55) 55
cutting edge (53) 53
immune cells (53) 53
skin and connective tissue diseases (53) 53
b-lymphocytes - drug effects (51) 51
belimumab (51) 51
immunity (50) 50
lymphocyte receptors (50) 50
member (50) 50
oncology (50) 50
t cells (50) 50
adolescent (49) 49
t-cells (49) 49
tnf receptor (49) 49
monoclonal antibodies (48) 48
cells, cultured (47) 47
disease-activity (47) 47
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 01/2012, Volume 7, Issue 1, p. e29371
We have recently identified conventional B2 cells as atherogenic and B1a cells as atheroprotective in hypercholesterolemic ApoE(-/-) mice. Here, we examined... 
IMMUNE | RESPONSES | VCAM-1 | ACTIVATING FACTOR BAFF | ENDOTHELIUM | BIOLOGY | IMMUNOGLOBULIN | T-CELL | ADHESION MOLECULES | POLARIZATION | LESIONS | Arteritis - genetics | Arteritis - pathology | Atherosclerosis - genetics | Male | Arteries - cytology | Arteries - metabolism | Endothelial Cells - classification | Inflammation Mediators - metabolism | Chemokine CCL2 - metabolism | B-Cell Activation Factor Receptor - genetics | Cytokines - genetics | Endothelial Cells - physiology | Atherosclerosis - pathology | Cytokines - metabolism | Endothelial Cells - metabolism | Mice, Inbred C57BL | Gene Expression Regulation | Arteritis - prevention & control | Atherosclerosis - complications | Chemokine CCL2 - genetics | Arteries - pathology | B-Cell Activation Factor Receptor - physiology | Atherosclerosis - metabolism | Mice, Knockout | Down-Regulation - physiology | Animals | Apolipoproteins E - genetics | Apolipoproteins E - physiology | Arteritis - complications | Cytoprotection - genetics | Mice | Endothelial Cells - pathology | Heart | Vascular cell adhesion molecule 1 | CD8 antigen | Body weight | Cardiovascular disease | Systematic review | Proliferating cell nuclear antigen | Aorta | Lupus | Spleen | Immunoglobulins | Cytokines | T cell receptors | Tumor necrosis factor-α | Gene expression | Apolipoproteins | Peritoneal fluid | Nursing | Arteriosclerosis | Weight reduction | Ligands | Monocyte chemoattractant protein 1 | Immunoglobulin M | Health sciences | Laboratories | Immunoglobulin G | Lipids | Lymphocytes T | Biology | Macrophages | Accumulation | Inflammatory diseases | Lymph nodes | High fat diet | Cell adhesion & migration | Lymphocytes | Apolipoprotein E | Rodents | Atherosclerosis | Interleukin 1 | Tumor necrosis factor-TNF | Lesions | Dendritic cells | Inflammation | CD4 antigen | Medicine | Lymphocytes B | BLyS protein | Bans | Diabetes | Fats and oils | Autoimmune diseases | Peritoneum
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2013, Volume 8, Issue 4, p. e60430
Aims: Option to attenuate atherosclerosis by depleting B2 cells is currently limited to anti-CD20 antibodies which deplete all B-cell subtypes. In the present... 
B-CELLS | SURVIVAL | CYTOKINES | CELL-ACTIVATING FACTOR | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | DISEASE | CD4(+) T-CELLS | E KNOCKOUT MICE | NATURAL IGM | AGGRAVATES ATHEROSCLEROSIS | Antigens, CD - immunology | Spleen - immunology | Apolipoproteins E - deficiency | Male | Spleen - drug effects | Lymphocyte Depletion | Antigens, CD - genetics | B-Cell Activation Factor Receptor - antagonists & inhibitors | Diet, High-Fat | B-Lymphocyte Subsets - immunology | Spleen - pathology | B-Cell Activation Factor Receptor - genetics | Antibodies, Monoclonal - immunology | Hyperlipidemias - complications | B-Cell Activation Factor Receptor - immunology | Cytokines - immunology | Hyperlipidemias - immunology | B-Lymphocyte Subsets - drug effects | Atherosclerosis - pathology | Atherosclerosis - drug therapy | Atherosclerosis - immunology | B-Lymphocyte Subsets - pathology | Antibodies, Monoclonal - pharmacology | Hyperlipidemias - drug therapy | Atherosclerosis - complications | Disease Progression | Mice, Knockout | Animals | Apolipoproteins E - genetics | Apolipoproteins E - immunology | Hyperlipidemias - pathology | Mice | Cytokines - biosynthesis | Heart | Health sciences | Vascular cell adhesion molecule 1 | Laboratories | CD8 antigen | Medical services | Lipids | Cardiovascular disease | Lymphocytes T | Biology | Inflammatory diseases | High fat diet | Immunology | Lymphocytes | Apolipoprotein E | Rodents | Atherosclerosis | Interleukin 1 | Lesions | Heart diseases | Spleen | Medical research | Antigens | Immunoglobulins | CD19 antigen | Cytokines | Inflammation | Tumor necrosis factor-α | Gene expression | Apolipoproteins | Thrombosis | CD4 antigen | Medicine | Nursing | Depletion | Lymphocytes B | BLyS protein | Arteriosclerosis | γ-Interferon | Monoclonal antibodies | CD20 antigen | TNF inhibitors | Bans | Diabetes | Autoimmune diseases | Cardiovascular diseases
Journal Article
The Journal of Immunology, ISSN 0022-1767, 09/2009, Volume 183, Issue 6, pp. 3561 - 3567
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2014, Volume 9, Issue 5, p. e96381
B cell development and activation are regulated by combined signals mediated by the B cell receptor (BCR), receptors for the B-cell activating factor of the... 
BAFF-R | SURVIVAL | SYSTEMIC-LUPUS-ERYTHEMATOSUS | CLASS SWITCH RECOMBINATION | TYROSINE KINASE | MULTIDISCIPLINARY SCIENCES | PKC-BETA | TERMINAL DIFFERENTIATION | AUTOIMMUNE-DISEASE | T-CELLS | I-KAPPA-B | Tumor Necrosis Factor-alpha - metabolism | Cell Proliferation - genetics | MAP Kinase Kinase Kinases - genetics | Humans | Tumor Necrosis Factor-alpha - genetics | Toll-Like Receptor 9 - genetics | NF-kappa B - metabolism | MAP Kinase Kinase Kinases - metabolism | Signal Transduction - genetics | Receptors, Antigen, B-Cell - metabolism | Lymphocyte Activation - genetics | Immunoglobulin G - genetics | NF-kappa B - genetics | Oligodeoxyribonucleotides - genetics | Mitogen-Activated Protein Kinases - genetics | Receptors, Antigen, B-Cell - genetics | Toll-Like Receptor 9 - metabolism | Oligodeoxyribonucleotides - metabolism | B-Lymphocytes - metabolism | Mitogen-Activated Protein Kinases - metabolism | Cell proliferation | Lymphocyte receptors | Phosphorylation | Crosstalk | Immunoglobulin G | Activation | Mitochondrial DNA | B-cell receptor | Blast | Kinases | Proteins | Ethics | Signal transduction | Receptors | Cell activation | Immunology | Pathways | Toll-like receptors | Tumor necrosis factor-TNF | Deoxyribonucleic acid--DNA | CpG islands | Immune system | Lupus | Antigens | Cytokines | Blood & organ donations | Secretion | TAK1 protein | Extracellular signal-regulated kinase | JNK protein | T cell receptors | siRNA | TLR9 protein | Signaling | Lymphocytes B | Tumor necrosis factor | BLyS protein | Collaboration | Rheumatoid arthritis | Ligands | Deoxyribonucleic acid | DNA
Journal Article
Blood, ISSN 0006-4971, 01/2011, Volume 117, Issue 1, pp. 200 - 210
Aberrant nuclear factor kappa B (NF-kappa B) signaling has been found to be of particular importance in diffuse, large B-cell lymphoma (DLBCL) cell survival... 
BAFF-R | TNF RECEPTOR | APOPTOSIS | NFAT ACTIVATION | GENE | NECROSIS-FACTOR FAMILY | REL | SURVIVAL SIGNALS | BLYS | HEMATOLOGY | EXPRESSION | RNA, Small Interfering - genetics | Phosphorylation | Cell Proliferation | Immunoprecipitation | Inhibitor of Apoptosis Proteins - genetics | Tissue Array Analysis | Humans | TNF Receptor-Associated Factor 2 - genetics | NF-kappa B - metabolism | Baculoviral IAP Repeat-Containing 3 Protein | I-kappa B Proteins - metabolism | Lymphoma, Large B-Cell, Diffuse - metabolism | I-kappa B Proteins - genetics | Immunoenzyme Techniques | B-Cell Activation Factor Receptor - antagonists & inhibitors | Cell Nucleus - metabolism | TNF Receptor-Associated Factor 3 - genetics | Inhibitor of Apoptosis Proteins - antagonists & inhibitors | Inhibitor of Apoptosis Proteins - metabolism | B-Cell Activation Factor Receptor - genetics | Protein-Serine-Threonine Kinases - metabolism | TNF Receptor-Associated Factor 3 - antagonists & inhibitors | NF-KappaB Inhibitor alpha | Lymphoma, Large B-Cell, Diffuse - pathology | Signal Transduction | RNA, Messenger - genetics | Protein-Serine-Threonine Kinases - genetics | TNF Receptor-Associated Factor 2 - metabolism | TNF Receptor-Associated Factor 3 - metabolism | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Ubiquitin-Protein Ligases | TNF Receptor-Associated Factor 2 - antagonists & inhibitors | B-Cell Activation Factor Receptor - metabolism | B-Cell Activating Factor - metabolism | NF-kappa B - genetics | B-Cell Activating Factor - genetics | Protein-Serine-Threonine Kinases - chemistry | Lymphoma, Large B-Cell, Diffuse - genetics | Lymphoid Neoplasia
Journal Article
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 05/2017, Volume 127, Issue 5, pp. 1651 - 1663
Mature B cell pools retain a substantial proportion of polyreactive and self-reactive clonotypes, suggesting that activation checkpoints exist to reduce the... 
MEDICINE, RESEARCH & EXPERIMENTAL | SYSTEMIC-LUPUS-ERYTHEMATOSUS | INTERFERON-GAMMA | TOLL-LIKE RECEPTOR-9 | MARGINAL ZONE | ESCAPE TOLERANCE | LYMPHOCYTE STIMULATOR | SOMATIC MUTATION | AUTOANTIBODY PRODUCTION | T-CELLS | CUTTING EDGE | Toll-Like Receptor 9 - genetics | Male | T-Box Domain Proteins - immunology | G1 Phase Cell Cycle Checkpoints - immunology | MAP Kinase Signaling System - immunology | Toll-Like Receptor 9 - immunology | Cell Differentiation - genetics | Interleukins - genetics | MAP Kinase Signaling System - genetics | Interleukins - immunology | B-Cell Activating Factor - immunology | Female | CD40 Antigens - genetics | Interferon-gamma - genetics | Cell Line | DNA - immunology | p38 Mitogen-Activated Protein Kinases - genetics | p38 Mitogen-Activated Protein Kinases - immunology | T-Box Domain Proteins - genetics | G1 Phase Cell Cycle Checkpoints - genetics | Receptors, Antigen, B-Cell - immunology | Mice, Knockout | Cell Differentiation - immunology | Animals | B-Lymphocytes - immunology | B-Cell Activating Factor - genetics | Interferon-gamma - immunology | Antigens - immunology | Receptors, Antigen, B-Cell - genetics | Mice | CD40 Antigens - immunology | Antigens | DNA | Cytokine receptors | TLR9 | Cellular signal transduction | Research | B cells | CD27 antigen | CD40 antigen | Laboratories | B-cell receptor | Kinases | Genotype & phenotype | Mitochondria | Cell activation | Lymphocytes | Cell cycle | Interleukin 21 | Toll-like receptors | Deoxyribonucleic acid--DNA | Immunization | Cell survival | Cytokines | Secretion | Cell division | T cell receptors | Survival | TLR9 protein | Immune response (humoral) | Medicine | Lymphocytes B | BLyS protein | Ligands | Interferon | Regulation | Autoimmune diseases | Apoptosis
Journal Article
by Xue, Y and Wang, T and Song, X and Li, M and Zeng, X
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2018, Volume 77, Issue Suppl 2, p. 1276
ObjectivesPrimary Sjogren Syndrom(pSS) is characterised by activitition of B cells, increased production of RNA-associated antibodies and elevated proportion... 
Lymphocyte receptors | CD27 antigen | Flow cytometry | Sjogren's syndrome | Animal models | TLR7 protein | Therapeutic applications | Gene expression | Patients | Lymphocytes B | BLyS protein | Toll-like receptors | Enzyme-linked immunosorbent assay
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2017, Volume 12, Issue 3, p. e0174249
Journal Article